TGFBI and cancer: In fact, even though Cat D KO cancer cells resulted in a reduction in metastatic potential in NOD-SCID mice, an immunodeficient mouse strain, TGFBI blockade failed to or marginally recovered the reduced metastatic potential of the Cat D KO cancer cells.